Business Description
Kobayashi Pharmaceutical Co Ltd
ISIN : JP3301100008
Share Class Description:
FRA:KOY: Ordinary SharesDescription
Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 80.89 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.04 | |||||
| Interest Coverage | 889.1 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 6.37 | |||||
| Beneish M-Score | -2.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.9 | |||||
| 3-Year EBITDA Growth Rate | 4.1 | |||||
| 3-Year EPS without NRI Growth Rate | 1.3 | |||||
| 3-Year FCF Growth Rate | -37.1 | |||||
| 3-Year Book Growth Rate | 5.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.33 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.64 | |||||
| 9-Day RSI | 46.81 | |||||
| 14-Day RSI | 45.16 | |||||
| 6-1 Month Momentum % | -20 | |||||
| 12-1 Month Momentum % | -39.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.82 | |||||
| Quick Ratio | 2.43 | |||||
| Cash Ratio | 1.42 | |||||
| Days Inventory | 112.89 | |||||
| Days Sales Outstanding | 91.68 | |||||
| Days Payable | 46.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.97 | |||||
| Dividend Payout Ratio | 0.37 | |||||
| 3-Year Dividend Growth Rate | 10.4 | |||||
| Forward Dividend Yield % | 2.33 | |||||
| 5-Year Yield-on-Cost % | 3.01 | |||||
| 3-Year Average Share Buyback Ratio | 1.7 | |||||
| Shareholder Yield % | 1.83 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.56 | |||||
| Operating Margin % | 14.87 | |||||
| Net Margin % | 11.73 | |||||
| FCF Margin % | 2.7 | |||||
| ROE % | 9.92 | |||||
| ROA % | 7.74 | |||||
| ROIC % | 14.27 | |||||
| ROC (Joel Greenblatt) % | 44.05 | |||||
| ROCE % | 13 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.15 | |||||
| PE Ratio without NRI | 20.21 | |||||
| Shiller PE Ratio | 22.85 | |||||
| PEG Ratio | 5.18 | |||||
| PS Ratio | 2.36 | |||||
| PB Ratio | 1.96 | |||||
| Price-to-Tangible-Book | 2.22 | |||||
| Price-to-Free-Cash-Flow | 85.51 | |||||
| Price-to-Operating-Cash-Flow | 22.31 | |||||
| EV-to-EBIT | 11.91 | |||||
| EV-to-EBITDA | 11.91 | |||||
| EV-to-Revenue | 1.89 | |||||
| EV-to-FCF | 67.36 | |||||
| Price-to-Projected-FCF | 1.33 | |||||
| Price-to-DCF (Earnings Based) | 0.93 | |||||
| Price-to-DCF (FCF Based) | 4.9 | |||||
| Price-to-Median-PS-Value | 0.65 | |||||
| Price-to-Graham-Number | 1.42 | |||||
| Price-to-Net-Current-Asset-Value | 4.25 | |||||
| Price-to-Net-Cash | 23.73 | |||||
| Earnings Yield (Greenblatt) % | 8.4 | |||||
| FCF Yield % | 1.17 | |||||
| Forward Rate of Return (Yacktman) % | 7.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kobayashi Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,130.456 | ||
| EPS (TTM) (€) | 1.743 | ||
| Beta | 0.38 | ||
| Volatility % | 29.97 | ||
| 14-Day RSI | 45.16 | ||
| 14-Day ATR (€) | 0.505736 | ||
| 20-Day SMA (€) | 32.42 | ||
| 12-1 Month Momentum % | -39.82 | ||
| 52-Week Range (€) | 28 - 55.5 | ||
| Shares Outstanding (Mil) | 74.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kobayashi Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kobayashi Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kobayashi Pharmaceutical Co Ltd Frequently Asked Questions
What is Kobayashi Pharmaceutical Co Ltd(FRA:KOY)'s stock price today?
The current price of FRA:KOY is €31.80. The 52 week high of FRA:KOY is €55.50 and 52 week low is €28.00.
When is next earnings date of Kobayashi Pharmaceutical Co Ltd(FRA:KOY)?
The next earnings date of Kobayashi Pharmaceutical Co Ltd(FRA:KOY) is 2024-05-15 Est..
Does Kobayashi Pharmaceutical Co Ltd(FRA:KOY) pay dividends? If so, how much?
The Dividend Yield %  of Kobayashi Pharmaceutical Co Ltd(FRA:KOY) is 1.97% (As of Today), Highest Dividend Payout Ratio of Kobayashi Pharmaceutical Co Ltd(FRA:KOY) was 0.38. The lowest was 0.27. And the median was 0.3. The  Forward Dividend Yield % of Kobayashi Pharmaceutical Co Ltd(FRA:KOY) is 2.33%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers